Navigation Links
Immunotherapy for elderly cancer patients finds new promise in drug combination
Date:4/15/2012

SAN ANTONIO (April 16, 2012) Cancer is much more likely in the elderly than the young, and their bodies often are less prepared to fight the disease and the often-toxic side effects of treatment.

But a new study from the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio shows that some types of immunotherapy previously thought to work only in younger patients can be used to help the elderly, with less toxic effects than many common therapies, if combined in ways that account for age-related changes in the immune system.

"We've shown that immunotherapy for cancer not only works in aged mice, but actually can work better in aged hosts than in young counterparts by capitalizing on the immune changes that happen with age," said Tyler Curiel, M.D., MPH, a professor in the School of Medicine at the Health Science Center and principal investigator of the study, published April 15 in Cancer Research.

As you age, most parts of your body begin to wear out. They keep doing what they're made to do, Dr. Curiel said, but over time, they don't do it as well. The general perception is that the immune system also simply declines with age. "That's really too simplistic," he said. "That's really not the full picture of what's happening."

The body's immune system does weaken with age, but it also changes, and that changes the rules for fighting disease within the body. Dr. Curiel's group started by examining an immune therapy that they previously had shown to work in younger hosts, including cancer patients. It's designed to eliminate regulatory T cells (called Tregs), which are cells that turn off immune responses, allowing cancer to progress. Tregs increase in cancer. In young hosts, the drug turns off Treg activity, allowing the immune system to function better. In older hosts, even though the drug turns off the Tregs, it has no clinical benefit.

Dr. Curiel asked the question
'/>"/>

Contact: Elizabeth Allen
allenea@uthscsa.edu
210-450-2020
University of Texas Health Science Center at San Antonio
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New universal platform for cancer immunotherapy developed by Penn-led team
2. Fred Hutchinson Cancer Research Center to lead Immunotherapy Clinical Trials Network
3. FDA approves ipilimumab, an immunotherapy, to treat metastatic melanoma
4. Novel immunotherapy drug receives FDA approval for the treatment of metastatic melanoma
5. Addition of immunotherapy boosts pediatric cancer survival in children with neuroblastoma
6. Combined BRAF-targeted and immunotherapy shows promise for melanoma treatment
7. Targeted immunotherapy shows promise for metastatic breast, pancreatic cancers
8. Dana-Farber/Provenge: Approval of prostate cancer immunotherapy-new era of cancer treatments
9. FDA Approval of new Prostate Treatment Shows Promise of Cancer Immunotherapy
10. Why is traumatic brain injury increasing among the elderly?
11. High blood glucose levels may increase kidney disease in elderly populations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 2015 Georgia State University’s School of ... that will partner with the school on efforts to ... nation that produces more tobacco and has more smokers ... China Tobacco Control Partnership-Tobacco Free Cities, will focus on ... to support tobacco control efforts and where public health ...
(Date:4/28/2015)... 2015 Tools4ever, the market leader ... today that they have been chosen by IT ... Identity and Access Management vendors. IT Central Station ... and Access Management tools by real users in ... analyzed their trends to come up with the ...
(Date:4/28/2015)... 28, 2015 A new survey from ... lung damage, 66 percent of Americans fear brain damage the ... Awareness Month in May, shed light on the need for ... help prevent a stroke. By controlling modifiable risk factors, ... stroke is a “ brain attack ” that occurs when ...
(Date:4/28/2015)... April 28, 2015 A first-in-human ... of Molecular Imaging and Biology showed initial safety, ... generation fluorine-18 labeled small-molecule PSMA inhibitor. The imaging ... in Baltimore, MD by study co-author, Martin G. ... evaluation of [18F]DCFPyL demonstrated a number of important ...
(Date:4/28/2015)... Colorado spine surgeon Donald Corenman, MD, ... popular spine education website NECKANDBACK.COM and his ... Media. This website has been redesigned to help patients ... spine, causes of neck and back pain, and conditions ... and personally answers questions in the neck and back ...
Breaking Medicine News(10 mins):Health News:Georgia State Names Partner Cities For Tobacco Control Project 2Health News:Tools4ever Chosen as Part of “Top Identity and Access Management Tools - 2015 Edition” 2Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 2Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 3Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 2Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 3Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 2Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 3
... , ATLANTA, Nov. 30 Kool Smiles received ... one of InfoWorld ,s Top 100 IT ... Kool Smiles built a Wyse-based thin-client infrastructure to support the electronic ... States. With this roll-out now complete, Kool Smiles has implemented ...
... , , ... million people become infected with HIV, and two million die from ... Day 2009 the Global AIDS Alliance (GAA) calls on President Obama ... the World Health Organization (WHO) showing that the AIDS pandemic continues ...
... , SEATTLE, Nov. 30 Major League Baseball,s ... recently acquired by the Chicago White Sox, will receive the 2009 ... Baseball player who best exemplifies the honor, courage and dedication of ... , The 28-year-old Redlands, Calif., native made his MLB ...
... While recognizing significant impact, CBO analysis understates the ... The Blue Cross and Blue Shield Association (BCBSA) ... by the Congressional Budget Office (CBO): , The CBO ... experts have said for weeks: the Senate healthcare reform ...
... for lifelong residents of ,stroke belt, study finds ... in the "stroke belt" of the southern United States have ... even if they live elsewhere later, a new study shows. ... the North and South Carolina, Georgia, Tennessee, Arkansas, Mississippi and ...
... equivalent to 113 chest X-rays, study finds , MONDAY, Nov. ... have abdominal/pelvic CT scans receive additional unnecessary imaging tests that ... the study, 978 CT abdominal and pelvic series were performed ... of the patients were 30 to 50 years of age. ...
Cached Medicine News:Health News:Kool Smiles Named Among 2009 InfoWorld 100 2Health News:GAA Calls on President Obama to Act on the Reality of AIDS 2Health News:GAA Calls on President Obama to Act on the Reality of AIDS 3Health News:Mark Teahen Named 2009 Hutch Award Winner 2Health News:CBO Confirms That Premiums Will Increase Under the Senate Healthcare Reform Bill 2Health News:Birth in South Raises Stroke Risk for Life 2Health News:Birth in South Raises Stroke Risk for Life 3Health News:CT Scan Patients May Get Unnecessary Imaging 2
(Date:4/28/2015)... , April 28, 2015 /CNW/ - The group representing the ... drug tragedy left a two-hour meeting with Health Canada ... March 6th, Health Canada announced a $180 million support ... than six weeks after the Health Canada announcement and ... fully support the victims, the group representing ...
(Date:4/28/2015)... Israel , April 28, 2015 ... in its sixth funding cycle for U.S.- Israel ... and Energy Efficiency. To be considered, a project ... between a company and a university/research institution (one from the ... proposal should have significant commercial potential and the project outcome ...
(Date:4/27/2015)... Intarcia Therapeutics, Inc. today announced the closing of ... conversion option at a $5.5 billion Company valuation. Plans ... of additional head-to-head comparative and switch studies of ITCA ... therapies. In addition, proceeds from the financing will fund ... 650 in the United States , ...
Breaking Medicine Technology:Thalidomide Victims Gravely Concerned by Health Canada's Silence 2Opportunities for Funding U.S.-Israel Cooperation for Renewable Energy and Efficiency 2Intarcia Therapeutics Closes Novel $225 Million Synthetic Royalty Financing With Equity Conversion Option At $5.5 Billion Valuation 2Intarcia Therapeutics Closes Novel $225 Million Synthetic Royalty Financing With Equity Conversion Option At $5.5 Billion Valuation 3
... , , PITTSBURGH, Jan. 11 ... global, private High-Definition broadcasting network, has engineered a ... for world-renowned pharmaceutical and medical device companies. ... Novartis, Shire, Schering-Plough, Bristol-Myers Squib, Cardiovascular Research Foundation ...
... Maine, Jan. 11 IDEXX Laboratories, Inc. (Nasdaq: ... of 2,000 Catalyst Dx® chemistry analyzers in 2009, bringing ... in the first quarter of 2008, is a next ... integrated suite of analyzers and significantly expands the range ...
Cached Medicine Technology:VELOCITY Broadcasting Injects ROI into Pharmaceutical Sector by Engaging Medical Professionals with Experiential High-Definition Broadcast Events 2VELOCITY Broadcasting Injects ROI into Pharmaceutical Sector by Engaging Medical Professionals with Experiential High-Definition Broadcast Events 3IDEXX Laboratories Announces Catalyst Dx(R) Placement Total for 2009 and Installed Base of SmartService(TM) Customers 2
... 233 is an assayed quality ... the measurements of total hemoglobin ... instrumentation. It is available in ... analyzer performance at varying points ...
... is an assayed quality control material for blood ... four (4) levels for monitoring analyzer performance at ... be used on multiple test analyzers (such as ... 600). QC623 is also for use on ITC ...
... an assayed quality control material used ... gas, electrolyte, metabolite, and CO-Oximeter instrumentation. ... makes it the ideal choice for ... available in three (3) levels for ...
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
Medicine Products: